Global and Japan Super Generic Drugs Market Insights, Forecast to 2027
SKU ID : QYR-19201632 | Publishing Date : 22-Sep-2021 | No. of pages : 165
Detailed TOC of Global and Japan Super Generic Drugs Market Insights, Forecast to 2027
1 Study Coverage1.1 Super Generic Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Super Generic Drugs Market Size Growth Rate by Type
1.2.2 Traditional Generic Drugs
1.2.3 Biosimilars
1.3 Market by Application
1.3.1 Global Super Generic Drugs Market Size Growth Rate by Application
1.3.2 CNS
1.3.3 Cardiovascular
1.3.4 Genitourinary/Hormonal Drugs
1.3.5 Respiratory
1.3.6 Rheumatology
1.3.7 Diabetes
1.3.8 Oncology
1.3.9 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Super Generic Drugs Market Size, Estimates and Forecasts
2.1.1 Global Super Generic Drugs Revenue 2016-2027
2.1.2 Global Super Generic Drugs Sales 2016-2027
2.2 Global Super Generic Drugs, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Super Generic Drugs Historical Market Size by Region (2016-2021)
2.3.1 Global Super Generic Drugs Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Super Generic Drugs Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Super Generic Drugs Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Super Generic Drugs Sales Forecast by Region (2022-2027)
2.4.2 Global Super Generic Drugs Revenue Forecast by Region (2022-2027)
3 Global Super Generic Drugs Competitor Landscape by Players
3.1 Global Top Super Generic Drugs Manufacturers by Sales
3.1.1 Global Super Generic Drugs Sales by Manufacturer (2016-2021)
3.1.2 Global Super Generic Drugs Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Super Generic Drugs Manufacturers by Revenue
3.2.1 Key Super Generic Drugs Manufacturers Covered: Ranking by Revenue
3.2.2 Global Super Generic Drugs Revenue by Manufacturers (2016-2021)
3.2.3 Global Super Generic Drugs Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Super Generic Drugs Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Super Generic Drugs Revenue in 2020
3.2.6 Global Super Generic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Super Generic Drugs Price by Manufacturers
3.4 Global Super Generic Drugs Manufacturing Base Distribution, Product Types
3.4.1 Super Generic Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Super Generic Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Super Generic Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Super Generic Drugs Market Size by Type (2016-2021)
4.1.1 Global Super Generic Drugs Sales by Type (2016-2021)
4.1.2 Global Super Generic Drugs Revenue by Type (2016-2021)
4.1.3 Super Generic Drugs Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Super Generic Drugs Market Size Forecast by Type (2022-2027)
4.2.1 Global Super Generic Drugs Sales Forecast by Type (2022-2027)
4.2.2 Global Super Generic Drugs Revenue Forecast by Type (2022-2027)
4.2.3 Super Generic Drugs Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Super Generic Drugs Market Size by Application (2016-2021)
5.1.1 Global Super Generic Drugs Sales by Application (2016-2021)
5.1.2 Global Super Generic Drugs Revenue by Application (2016-2021)
5.1.3 Super Generic Drugs Price by Application (2016-2021)
5.2 Super Generic Drugs Market Size Forecast by Application (2022-2027)
5.2.1 Global Super Generic Drugs Sales Forecast by Application (2022-2027)
5.2.2 Global Super Generic Drugs Revenue Forecast by Application (2022-2027)
5.2.3 Global Super Generic Drugs Price Forecast by Application (2022-2027)
6 Japan by Players, Type and Application
6.1 Japan Super Generic Drugs Market Size YoY Growth 2016-2027
6.1.1 Japan Super Generic Drugs Sales YoY Growth 2016-2027
6.1.2 Japan Super Generic Drugs Revenue YoY Growth 2016-2027
6.1.3 Japan Super Generic Drugs Market Share in Global Market 2016-2027
6.2 Japan Super Generic Drugs Market Size by Players (International and Local Players)
6.2.1 Japan Top Super Generic Drugs Players by Sales (2016-2021)
6.2.2 Japan Top Super Generic Drugs Players by Revenue (2016-2021)
6.3 Japan Super Generic Drugs Historic Market Review by Type (2016-2021)
6.3.1 Japan Super Generic Drugs Sales Market Share by Type (2016-2021)
6.3.2 Japan Super Generic Drugs Revenue Market Share by Type (2016-2021)
6.3.3 Japan Super Generic Drugs Price by Type (2016-2021)
6.4 Japan Super Generic Drugs Market Estimates and Forecasts by Type (2022-2027)
6.4.1 Japan Super Generic Drugs Sales Forecast by Type (2022-2027)
6.4.2 Japan Super Generic Drugs Revenue Forecast by Type (2022-2027)
6.4.3 Japan Super Generic Drugs Price Forecast by Type (2022-2027)
6.5 Japan Super Generic Drugs Historic Market Review by Application (2016-2021)
6.5.1 Japan Super Generic Drugs Sales Market Share by Application (2016-2021)
6.5.2 Japan Super Generic Drugs Revenue Market Share by Application (2016-2021)
6.5.3 Japan Super Generic Drugs Price by Application (2016-2021)
6.6 Japan Super Generic Drugs Market Estimates and Forecasts by Application (2022-2027)
6.6.1 Japan Super Generic Drugs Sales Forecast by Application (2022-2027)
6.6.2 Japan Super Generic Drugs Revenue Forecast by Application (2022-2027)
6.6.3 Japan Super Generic Drugs Price Forecast by Application (2022-2027)
7 North America
7.1 North America Super Generic Drugs Market Size YoY Growth 2016-2027
7.2 North America Super Generic Drugs Market Facts & Figures by Country
7.2.1 North America Super Generic Drugs Sales by Country (2016-2021)
7.2.2 North America Super Generic Drugs Revenue by Country (2016-2021)
7.2.3 United States
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Super Generic Drugs Market Size YoY Growth 2016-2027
8.2 Asia Pacific Super Generic Drugs Market Facts & Figures by Region
8.2.1 Asia Pacific Super Generic Drugs Sales by Region (2016-2021)
8.2.2 Asia Pacific Super Generic Drugs Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Super Generic Drugs Market Size YoY Growth 2016-2027
9.2 Europe Super Generic Drugs Market Facts & Figures by Country
9.2.1 Europe Super Generic Drugs Sales by Country (2016-2021)
9.2.2 Europe Super Generic Drugs Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Super Generic Drugs Market Size YoY Growth 2016-2027
10.2 Latin America Super Generic Drugs Market Facts & Figures by Country
10.2.1 Latin America Super Generic Drugs Sales by Country (2016-2021)
10.2.2 Latin America Super Generic Drugs Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Super Generic Drugs Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Super Generic Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Super Generic Drugs Sales by Country (2016-2021)
11.2.2 Middle East and Africa Super Generic Drugs Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Teva
12.1.1 Teva Corporation Information
12.1.2 Teva Description and Business Overview
12.1.3 Teva Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Teva Super Generic Drugs Products Offered
12.1.5 Teva Recent Development
12.2 Novartis - Sandoz
12.2.1 Novartis - Sandoz Corporation Information
12.2.2 Novartis - Sandoz Description and Business Overview
12.2.3 Novartis - Sandoz Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Novartis - Sandoz Super Generic Drugs Products Offered
12.2.5 Novartis - Sandoz Recent Development
12.3 Mylan
12.3.1 Mylan Corporation Information
12.3.2 Mylan Description and Business Overview
12.3.3 Mylan Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Mylan Super Generic Drugs Products Offered
12.3.5 Mylan Recent Development
12.4 Sun Pharmaceutical
12.4.1 Sun Pharmaceutical Corporation Information
12.4.2 Sun Pharmaceutical Description and Business Overview
12.4.3 Sun Pharmaceutical Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Sun Pharmaceutical Super Generic Drugs Products Offered
12.4.5 Sun Pharmaceutical Recent Development
12.5 Aspen
12.5.1 Aspen Corporation Information
12.5.2 Aspen Description and Business Overview
12.5.3 Aspen Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Aspen Super Generic Drugs Products Offered
12.5.5 Aspen Recent Development
12.6 Fresenius Kabi
12.6.1 Fresenius Kabi Corporation Information
12.6.2 Fresenius Kabi Description and Business Overview
12.6.3 Fresenius Kabi Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Fresenius Kabi Super Generic Drugs Products Offered
12.6.5 Fresenius Kabi Recent Development
12.7 Pfizer (Hospira)
12.7.1 Pfizer (Hospira) Corporation Information
12.7.2 Pfizer (Hospira) Description and Business Overview
12.7.3 Pfizer (Hospira) Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Pfizer (Hospira) Super Generic Drugs Products Offered
12.7.5 Pfizer (Hospira) Recent Development
12.8 Sanofi
12.8.1 Sanofi Corporation Information
12.8.2 Sanofi Description and Business Overview
12.8.3 Sanofi Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Sanofi Super Generic Drugs Products Offered
12.8.5 Sanofi Recent Development
12.9 Aurobindo
12.9.1 Aurobindo Corporation Information
12.9.2 Aurobindo Description and Business Overview
12.9.3 Aurobindo Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Aurobindo Super Generic Drugs Products Offered
12.9.5 Aurobindo Recent Development
12.10 Lupin
12.10.1 Lupin Corporation Information
12.10.2 Lupin Description and Business Overview
12.10.3 Lupin Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Lupin Super Generic Drugs Products Offered
12.10.5 Lupin Recent Development
12.11 Teva
12.11.1 Teva Corporation Information
12.11.2 Teva Description and Business Overview
12.11.3 Teva Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Teva Super Generic Drugs Products Offered
12.11.5 Teva Recent Development
12.12 Apotex
12.12.1 Apotex Corporation Information
12.12.2 Apotex Description and Business Overview
12.12.3 Apotex Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Apotex Products Offered
12.12.5 Apotex Recent Development
12.13 Cipla
12.13.1 Cipla Corporation Information
12.13.2 Cipla Description and Business Overview
12.13.3 Cipla Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Cipla Products Offered
12.13.5 Cipla Recent Development
12.14 ENDO (Par Pharmaceutical)
12.14.1 ENDO (Par Pharmaceutical) Corporation Information
12.14.2 ENDO (Par Pharmaceutical) Description and Business Overview
12.14.3 ENDO (Par Pharmaceutical) Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.14.4 ENDO (Par Pharmaceutical) Products Offered
12.14.5 ENDO (Par Pharmaceutical) Recent Development
12.15 Stada Arzneimittel
12.15.1 Stada Arzneimittel Corporation Information
12.15.2 Stada Arzneimittel Description and Business Overview
12.15.3 Stada Arzneimittel Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Stada Arzneimittel Products Offered
12.15.5 Stada Arzneimittel Recent Development
12.16 Krka Group
12.16.1 Krka Group Corporation Information
12.16.2 Krka Group Description and Business Overview
12.16.3 Krka Group Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Krka Group Products Offered
12.16.5 Krka Group Recent Development
12.17 Nichi-Iko Pharmaceutical
12.17.1 Nichi-Iko Pharmaceutical Corporation Information
12.17.2 Nichi-Iko Pharmaceutical Description and Business Overview
12.17.3 Nichi-Iko Pharmaceutical Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Nichi-Iko Pharmaceutical Products Offered
12.17.5 Nichi-Iko Pharmaceutical Recent Development
12.18 Valeant
12.18.1 Valeant Corporation Information
12.18.2 Valeant Description and Business Overview
12.18.3 Valeant Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Valeant Products Offered
12.18.5 Valeant Recent Development
12.19 Zydus Cadila
12.19.1 Zydus Cadila Corporation Information
12.19.2 Zydus Cadila Description and Business Overview
12.19.3 Zydus Cadila Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Zydus Cadila Products Offered
12.19.5 Zydus Cadila Recent Development
12.20 Hikma
12.20.1 Hikma Corporation Information
12.20.2 Hikma Description and Business Overview
12.20.3 Hikma Super Generic Drugs Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Hikma Products Offered
12.20.5 Hikma Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Super Generic Drugs Industry Trends
13.2 Super Generic Drugs Market Drivers
13.3 Super Generic Drugs Market Challenges
13.4 Super Generic Drugs Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Super Generic Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global and Japan Super Generic Drugs Market Insights, Forecast to 2027
List of TablesTable 1. Global Super Generic Drugs Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Traditional Generic Drugs
Table 3. Major Manufacturers of Biosimilars
Table 4. Global Super Generic Drugs Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 5. Global Super Generic Drugs Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global Super Generic Drugs Sales by Regions (2016-2021) & (K Units)
Table 7. Global Super Generic Drugs Sales Market Share by Regions (2016-2021)
Table 8. Global Super Generic Drugs Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global Super Generic Drugs Sales Forecast by Region (2022-2027) & (K Units)
Table 10. Global Super Generic Drugs Sales Market Share Forecast by Region (2022-2027)
Table 11. Global Super Generic Drugs Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global Super Generic Drugs Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global Super Generic Drugs Sales by Manufacturers (2016-2021) (K Units)
Table 14. Global Super Generic Drugs Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top Super Generic Drugs Manufacturers by Revenue (US$ Million) in 2020
Table 16. Super Generic Drugs Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. Super Generic Drugs Revenue Share by Manufacturers (2016-2021)
Table 18. Global Super Generic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global Super Generic Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Super Generic Drugs as of 2020)
Table 20. Key Manufacturers Super Generic Drugs Price (2016-2021) (US$/Unit)
Table 21. Super Generic Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Super Generic Drugs Product Type
Table 23. Date of International Manufacturers Enter into Super Generic Drugs Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Super Generic Drugs Sales by Type (2016-2021) (K Units)
Table 26. Global Super Generic Drugs Sales Share by Type (2016-2021)
Table 27. Global Super Generic Drugs Revenue by Type (2016-2021) (US$ Million)
Table 28. Global Super Generic Drugs Revenue Share by Type (2016-2021)
Table 29. Super Generic Drugs Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 30. Global Super Generic Drugs Sales Forecast by Type (2022-2027) & (K Units)
Table 31. Global Super Generic Drugs Sales Market Share Forecast by Type (2022-2027)
Table 32. Global Super Generic Drugs Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global Super Generic Drugs Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global Super Generic Drugs Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 35. Global Super Generic Drugs Sales by Application (2016-2021) (K Units)
Table 36. Global Super Generic Drugs Sales Share by Application (2016-2021)
Table 37. Global Super Generic Drugs Revenue by Application (2016-2021) (US$ Million)
Table 38. Global Super Generic Drugs Revenue Share by Application (2016-2021)
Table 39. Super Generic Drugs Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 40. Global Super Generic Drugs Sales Forecast by Application (2022-2027) & (K Units)
Table 41. Global Super Generic Drugs Sales Market Share Forecast by Application (2022-2027)
Table 42. Global Super Generic Drugs Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global Super Generic Drugs Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global Super Generic Drugs Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 45. Japan Super Generic Drugs Sales (K Units) of Key Companies (2016-2021)
Table 46. Japan Super Generic Drugs Sales Share by Company (2016-2021)
Table 47. Japan Super Generic Drugs Revenue (US$ Million) by Company (2016-2021)
Table 48. Japan Super Generic Drugs Revenue Share by Company (2016-2021)
Table 49. Japan Super Generic Drugs Sales (K Units) by Type (2016-2021)
Table 50. Japan Super Generic Drugs Sales Share by Type (2016-2021)
Table 51. Japan Super Generic Drugs Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. Japan Super Generic Drugs Price (US$/Unit) by Type (2016-2021)
Table 53. Japan Super Generic Drugs Sales (K Units) by Type (2022-2027)
Table 54. Japan Super Generic Drugs Sales Share by Type (2022-2027)
Table 55. Japan Super Generic Drugs Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. Japan Super Generic Drugs Revenue Share by Type (2022-2027)
Table 57. Japan Super Generic Drugs Price (US$/Unit) by Type (2022-2027)
Table 58. Japan Super Generic Drugs Sales (K Units) by Application (2016-2021)
Table 59. Japan Super Generic Drugs Sales Share by Application (2016-2021)
Table 60. Japan Super Generic Drugs Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. Japan Super Generic Drugs Price (US$/Unit) by Application (2016-2021)
Table 62. Japan Super Generic Drugs Sales (K Units) by Application (2022-2027)
Table 63. Japan Super Generic Drugs Sales Share by Application (2022-2027)
Table 64. Japan Super Generic Drugs Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. Japan Super Generic Drugs Revenue Share by Application (2022-2027)
Table 66. Japan Super Generic Drugs Price (US$/Unit) by Application (2022-2027)
Table 67. North America Super Generic Drugs Sales by Country (2016-2021) & (K Units)
Table 68. North America Super Generic Drugs Sales Market Share by Country (2016-2021)
Table 69. North America Super Generic Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America Super Generic Drugs Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific Super Generic Drugs Sales by Region (2016-2021) & (K Units)
Table 72. Asia Pacific Super Generic Drugs Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific Super Generic Drugs Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific Super Generic Drugs Revenue Market Share by Region (2016-2021)
Table 75. Europe Super Generic Drugs Sales by Country (2016-2021) & (K Units)
Table 76. Europe Super Generic Drugs Sales Market Share by Country (2016-2021)
Table 77. Europe Super Generic Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe Super Generic Drugs Revenue Market Share by Country (2016-2021)
Table 79. Latin America Super Generic Drugs Sales by Country (2016-2021) & (K Units)
Table 80. Latin America Super Generic Drugs Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa Super Generic Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America Super Generic Drugs Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa Super Generic Drugs Sales by Country (2016-2021) & (K Units)
Table 84. Middle East and Africa Super Generic Drugs Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa Super Generic Drugs Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa Super Generic Drugs Revenue Market Share by Country (2016-2021)
Table 87. Teva Corporation Information
Table 88. Teva Description and Business Overview
Table 89. Teva Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 90. Teva Super Generic Drugs Product
Table 91. Teva Recent Development
Table 92. Novartis - Sandoz Corporation Information
Table 93. Novartis - Sandoz Description and Business Overview
Table 94. Novartis - Sandoz Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 95. Novartis - Sandoz Product
Table 96. Novartis - Sandoz Recent Development
Table 97. Mylan Corporation Information
Table 98. Mylan Description and Business Overview
Table 99. Mylan Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 100. Mylan Product
Table 101. Mylan Recent Development
Table 102. Sun Pharmaceutical Corporation Information
Table 103. Sun Pharmaceutical Description and Business Overview
Table 104. Sun Pharmaceutical Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 105. Sun Pharmaceutical Product
Table 106. Sun Pharmaceutical Recent Development
Table 107. Aspen Corporation Information
Table 108. Aspen Description and Business Overview
Table 109. Aspen Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 110. Aspen Product
Table 111. Aspen Recent Development
Table 112. Fresenius Kabi Corporation Information
Table 113. Fresenius Kabi Description and Business Overview
Table 114. Fresenius Kabi Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 115. Fresenius Kabi Product
Table 116. Fresenius Kabi Recent Development
Table 117. Pfizer (Hospira) Corporation Information
Table 118. Pfizer (Hospira) Description and Business Overview
Table 119. Pfizer (Hospira) Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 120. Pfizer (Hospira) Product
Table 121. Pfizer (Hospira) Recent Development
Table 122. Sanofi Corporation Information
Table 123. Sanofi Description and Business Overview
Table 124. Sanofi Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 125. Sanofi Product
Table 126. Sanofi Recent Development
Table 127. Aurobindo Corporation Information
Table 128. Aurobindo Description and Business Overview
Table 129. Aurobindo Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 130. Aurobindo Product
Table 131. Aurobindo Recent Development
Table 132. Lupin Corporation Information
Table 133. Lupin Description and Business Overview
Table 134. Lupin Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 135. Lupin Product
Table 136. Lupin Recent Development
Table 137. Dr. Reddy's Corporation Information
Table 138. Dr. Reddy's Description and Business Overview
Table 139. Dr. Reddy's Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 140. Dr. Reddy's Product
Table 141. Dr. Reddy's Recent Development
Table 142. Apotex Corporation Information
Table 143. Apotex Description and Business Overview
Table 144. Apotex Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 145. Apotex Product
Table 146. Apotex Recent Development
Table 147. Cipla Corporation Information
Table 148. Cipla Description and Business Overview
Table 149. Cipla Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 150. Cipla Product
Table 151. Cipla Recent Development
Table 152. ENDO (Par Pharmaceutical) Corporation Information
Table 153. ENDO (Par Pharmaceutical) Description and Business Overview
Table 154. ENDO (Par Pharmaceutical) Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 155. ENDO (Par Pharmaceutical) Product
Table 156. ENDO (Par Pharmaceutical) Recent Development
Table 157. Stada Arzneimittel Corporation Information
Table 158. Stada Arzneimittel Description and Business Overview
Table 159. Stada Arzneimittel Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 160. Stada Arzneimittel Product
Table 161. Stada Arzneimittel Recent Development
Table 162. Krka Group Corporation Information
Table 163. Krka Group Description and Business Overview
Table 164. Krka Group Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 165. Krka Group Product
Table 166. Krka Group Recent Development
Table 167. Nichi-Iko Pharmaceutical Corporation Information
Table 168. Nichi-Iko Pharmaceutical Description and Business Overview
Table 169. Nichi-Iko Pharmaceutical Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 170. Nichi-Iko Pharmaceutical Product
Table 171. Nichi-Iko Pharmaceutical Recent Development
Table 172. Valeant Corporation Information
Table 173. Valeant Description and Business Overview
Table 174. Valeant Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 175. Valeant Product
Table 176. Valeant Recent Development
Table 177. Zydus Cadila Corporation Information
Table 178. Zydus Cadila Description and Business Overview
Table 179. Zydus Cadila Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 180. Zydus Cadila Product
Table 181. Zydus Cadila Recent Development
Table 182. Hikma Corporation Information
Table 183. Hikma Description and Business Overview
Table 184. Hikma Super Generic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 185. Hikma Product
Table 186. Hikma Recent Development
Table 187. Super Generic Drugs Market Trends
Table 188. Super Generic Drugs Market Drivers
Table 189. Super Generic Drugs Market Challenges
Table 190. Super Generic Drugs Market Restraints
Table 191. Super Generic Drugs Customers List
Table 192. Super Generic Drugs Distributors List
Table 193. Research Programs/Design for This Report
Table 194. Key Data Information from Secondary Sources
Table 195. Key Data Information from Primary Sources
List of Figures
Figure 1. Super Generic Drugs Product Picture
Figure 2. Global Super Generic Drugs Sales Market Share by Type in 2020 & 2027
Figure 3. Traditional Generic Drugs Product Picture
Figure 4. Biosimilars Product Picture
Figure 5. Global Super Generic Drugs Sales Market Share by Application in 2020 & 2027
Figure 6. CNS
Figure 7. Cardiovascular
Figure 8. Genitourinary/Hormonal Drugs
Figure 9. Respiratory
Figure 10. Rheumatology
Figure 11. Diabetes
Figure 12. Oncology
Figure 13. Others
Figure 14. Super Generic Drugs Report Years Considered
Figure 15. Global Super Generic Drugs Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Super Generic Drugs Market Size 2016-2027 (US$ Million)
Figure 17. Global Super Generic Drugs Sales 2016-2027 (K Units)
Figure 18. Global Super Generic Drugs Market Size Market Share by Region: 2021 Versus 2027
Figure 19. Global Super Generic Drugs Sales Market Share by Region (2016-2021)
Figure 20. Global Super Generic Drugs Sales Market Share by Region in 2020
Figure 21. Global Super Generic Drugs Revenue Market Share by Region (2016-2021)
Figure 22. Global Super Generic Drugs Revenue Market Share by Region in 2020
Figure 23. Global Super Generic Drugs Sales Share by Manufacturer in 2020
Figure 24. The Top 10 and 5 Players Market Share by Super Generic Drugs Revenue in 2020
Figure 25. Super Generic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 26. Global Super Generic Drugs Sales Market Share by Type (2016-2021)
Figure 27. Global Super Generic Drugs Sales Market Share by Type in 2020
Figure 28. Global Super Generic Drugs Revenue Market Share by Type (2016-2021)
Figure 29. Global Super Generic Drugs Revenue Market Share by Type in 2020
Figure 30. Global Super Generic Drugs Sales Market Share by Application (2016-2021)
Figure 31. Global Super Generic Drugs Sales Market Share by Application in 2020
Figure 32. Global Super Generic Drugs Revenue Market Share by Application (2016-2021)
Figure 33. Global Super Generic Drugs Revenue Market Share by Application in 2020
Figure 34. Japan Super Generic Drugs Sales Growth Rate 2016-2027 (K Units)
Figure 35. Japan Super Generic Drugs Revenue Growth Rate 2016-2027 (US$ Million)
Figure 36. Japan Super Generic Drugs Market Share in Global Market 2016-2027
Figure 37. Japan 5 and 10 Largest Super Generic Drugs Players Market Share by Revenue in Super Generic Drugs in 2020
Figure 38. Japan Super Generic Drugs Revenue Share by Type (2016-2021)
Figure 39. Japan Super Generic Drugs Revenue Growth Rate by Type in 2016 & 2020
Figure 40. Japan Super Generic Drugs Revenue Share by Application (2016-2021)
Figure 41. Japan Super Generic Drugs Revenue Growth Rate by Application in 2016 & 2020
Figure 42. North America Super Generic Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 43. North America Super Generic Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 44. North America Super Generic Drugs Sales Market Share by Country in 2020
Figure 45. North America Super Generic Drugs Revenue Market Share by Country in 2020
Figure 46. United States Super Generic Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 47. United States Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Canada Super Generic Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 49. Canada Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Europe Super Generic Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 51. Europe Super Generic Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 52. Europe Super Generic Drugs Sales Market Share by Country in 2020
Figure 53. Europe Super Generic Drugs Revenue Market Share by Country in 2020
Figure 54. Germany Super Generic Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 55. Germany Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. France Super Generic Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 57. France Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. U.K. Super Generic Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 59. U.K. Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Italy Super Generic Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 61. Italy Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 62. Russia Super Generic Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 63. Russia Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Asia Pacific Super Generic Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 65. Asia Pacific Super Generic Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 66. Asia Pacific Super Generic Drugs Sales Market Share by Region in 2020
Figure 67. Asia Pacific Super Generic Drugs Revenue Market Share by Region in 2020
Figure 68. China Super Generic Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 69. China Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. Japan Super Generic Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 71. Japan Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. South Korea Super Generic Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 73. South Korea Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. India Super Generic Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 75. India Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Australia Super Generic Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 77. Australia Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. China Taiwan Super Generic Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 79. China Taiwan Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Indonesia Super Generic Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 81. Indonesia Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Thailand Super Generic Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 83. Thailand Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Malaysia Super Generic Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 85. Malaysia Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Latin America Super Generic Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 87. Latin America Super Generic Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 88. Latin America Super Generic Drugs Sales Market Share by Country in 2020
Figure 89. Latin America Super Generic Drugs Revenue Market Share by Country in 2020
Figure 90. Mexico Super Generic Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 91. Mexico Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Brazil Super Generic Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 93. Brazil Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Argentina Super Generic Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 95. Argentina Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 96. Middle East and Africa Super Generic Drugs Sales Growth Rate 2016-2021 (K Units)
Figure 97. Middle East and Africa Super Generic Drugs Revenue Growth Rate 2016-2021 (US$ Million)
Figure 98. Middle East and Africa Super Generic Drugs Sales Market Share by Country in 2020
Figure 99. Middle East and Africa Super Generic Drugs Revenue Market Share by Country in 2020
Figure 100. Turkey Super Generic Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 101. Turkey Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. Saudi Arabia Super Generic Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 103. Saudi Arabia Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. UAE Super Generic Drugs Sales Growth Rate (2016-2021) (K Units)
Figure 105. UAE Super Generic Drugs Revenue Growth Rate (2016-2021) (US$ Million)
Figure 106. Super Generic Drugs Value Chain
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Bottom-up and Top-down Approaches for This Report
Figure 110. Data Triangulation
Figure 111. Key Executives Interviewed
Keyplayers in Global and Japan Super Generic Drugs Market Insights, Forecast to 2027
TevaNovartis - Sandoz
Mylan
Sun Pharmaceutical
Aspen
Fresenius Kabi
Pfizer (Hospira)
Sanofi
Aurobindo
Lupin
Dr. Reddy's
Apotex
Cipla
ENDO (Par Pharmaceutical)
Stada Arzneimittel
Krka Group
Nichi-Iko Pharmaceutical
Valeant
Zydus Cadila
Hikma